JPWO2020059891A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020059891A5
JPWO2020059891A5 JP2020549244A JP2020549244A JPWO2020059891A5 JP WO2020059891 A5 JPWO2020059891 A5 JP WO2020059891A5 JP 2020549244 A JP2020549244 A JP 2020549244A JP 2020549244 A JP2020549244 A JP 2020549244A JP WO2020059891 A5 JPWO2020059891 A5 JP WO2020059891A5
Authority
JP
Japan
Prior art keywords
general formula
compound represented
formula
defined above
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020549244A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020059891A1 (ja
JP7523354B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/037399 external-priority patent/WO2020059891A1/ja
Publication of JPWO2020059891A1 publication Critical patent/JPWO2020059891A1/ja
Publication of JPWO2020059891A5 publication Critical patent/JPWO2020059891A5/ja
Priority to JP2024076378A priority Critical patent/JP7790473B2/ja
Application granted granted Critical
Publication of JP7523354B2 publication Critical patent/JP7523354B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020549244A 2018-09-21 2019-09-24 アミノ酸誘導体の製造方法 Active JP7523354B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024076378A JP7790473B2 (ja) 2018-09-21 2024-05-09 アミノ酸誘導体の製造方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018177774 2018-09-21
JP2018177774 2018-09-21
PCT/JP2019/037399 WO2020059891A1 (ja) 2018-09-21 2019-09-24 アミノ酸誘導体の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024076378A Division JP7790473B2 (ja) 2018-09-21 2024-05-09 アミノ酸誘導体の製造方法

Publications (3)

Publication Number Publication Date
JPWO2020059891A1 JPWO2020059891A1 (ja) 2021-08-30
JPWO2020059891A5 true JPWO2020059891A5 (https=) 2022-10-03
JP7523354B2 JP7523354B2 (ja) 2024-07-26

Family

ID=69887293

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020549244A Active JP7523354B2 (ja) 2018-09-21 2019-09-24 アミノ酸誘導体の製造方法
JP2024076378A Active JP7790473B2 (ja) 2018-09-21 2024-05-09 アミノ酸誘導体の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024076378A Active JP7790473B2 (ja) 2018-09-21 2024-05-09 アミノ酸誘導体の製造方法

Country Status (5)

Country Link
US (3) US11897844B2 (https=)
EP (1) EP3854786B1 (https=)
JP (2) JP7523354B2 (https=)
CN (2) CN119707784A (https=)
WO (1) WO2020059891A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119707784A (zh) * 2018-09-21 2025-03-28 株式会社Api 氨基酸衍生物的制备方法
KR102698832B1 (ko) * 2022-09-14 2024-08-26 김형식 엑토인의 제조방법

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2533826T3 (es) 2008-01-18 2015-04-15 Merck Sharp & Dohme Corp. Inhibidores de beta-lactamasa
US20120053350A1 (en) 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
JP2013516422A (ja) * 2009-12-30 2013-05-13 アビラ セラピューティクス, インコーポレイテッド タンパク質のリガンド−指向性共有的修飾
SI2657234T1 (sl) * 2010-12-22 2017-06-30 Meiji Seika Pharma Co., Ltd. Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo
US8772490B2 (en) * 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
KR102143660B1 (ko) * 2011-06-17 2020-08-11 화이자 안티-인펙티브스 에이비 트랜스-7-옥소-6-(술포옥시)-1,6-디아자비시클로[3,2,1]옥탄-2-카르복스아미드 및 그의 염을 포함하는 헤테로시클릭 화합물의 제조 방법
TW201343645A (zh) * 2012-03-30 2013-11-01 Cubist Pharm Inc 1,3,4-□二唑及1,3,4-噻二唑β-內醯胺酶抑制劑
US8969570B2 (en) * 2012-03-30 2015-03-03 Cubist Pharmaceuticals, Inc. Beta-lactamase inhibitors
RU2693898C2 (ru) 2012-05-30 2019-07-05 Мейдзи Сейка Фарма Ко., Лтд. НОВЫЙ ИНГИБИТОР бета-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ
ES2693568T3 (es) * 2012-12-20 2018-12-12 Api Corporation Método para producir un derivado de ácido cis-5-hidroxi-2-piperidincarboxílico, y método para purificar ácido cis-5-hidroxi-2-piperidincarboxílico
CN104685061B (zh) 2013-02-19 2018-05-01 株式会社Api L-赖氨酸羟化酶和利用了该l-赖氨酸羟化酶的羟基-l-赖氨酸的制造法及羟基-l-2-哌啶酸的制造法
US9120795B2 (en) * 2013-03-14 2015-09-01 Cubist Pharmaceuticals, Inc. Crystalline form of a β-lactamase inhibitor
AU2014278556B2 (en) * 2013-06-10 2018-07-19 Merck Sharp & Dohme Llc Preparation of tert-butyl 4-((1R,2S,5R)-6- (benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2- carboxamido)piperidine-1-carboxylate
DK3050883T3 (da) * 2013-09-24 2020-05-25 Meiji Seika Pharma Co Ltd Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter
EP3613740A1 (en) * 2013-10-08 2020-02-26 Meiji Seika Pharma Co., Ltd. Preparation of a diazabicyclooctane derivative
JP6539212B2 (ja) 2013-12-26 2019-07-03 株式会社カネカ 光学活性環状イミノ酸の製造方法
JP6687238B2 (ja) 2013-12-27 2020-04-22 株式会社エーピーアイ コーポレーション 5−ヒドロキシピペリジン−2−カルボン酸の製造方法
WO2015173779A1 (en) 2014-05-16 2015-11-19 Micro Labs Limited Process for the preparation of teneligliptin and its novel intermediates
US10087139B2 (en) * 2015-03-03 2018-10-02 Toray Fine Chemicals Co., Ltd. 3-Phenylisoserine derivative production method
CN105061425B (zh) * 2015-08-13 2017-01-11 广州楷模生物科技有限公司 二氮杂双环辛酮硫酸单酯的合成方法
EP3281942A4 (en) * 2015-09-16 2018-08-15 Xuanzhu Pharma Co., Ltd. B-lactamase inhibitor and application thereof
CN106749242B (zh) * 2015-11-23 2021-04-02 上海医药工业研究院 阿维巴坦中间体的制备方法
US10501464B2 (en) * 2015-12-11 2019-12-10 Wockhardt Limited 7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide containing compounds and their use in treating bacterial infections
WO2017167218A1 (zh) * 2016-03-31 2017-10-05 山东轩竹医药科技有限公司 一种抗菌组合物及其用途
JOP20190061A1 (ar) * 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
US20200325139A1 (en) * 2017-12-22 2020-10-15 Assistance Publique-Hopitaux De Paris New antibiotics targeting mycobacteria
CN109970625B (zh) * 2017-12-28 2021-02-26 新发药业有限公司 一种5r-苄氧氨基哌啶-2s-甲酸或其衍生物的制备方法
CN119707784A (zh) * 2018-09-21 2025-03-28 株式会社Api 氨基酸衍生物的制备方法
CN114206851B (zh) * 2019-04-26 2025-02-11 默沙东有限责任公司 可用于制备(2s,5r)-7-氧代-n-哌啶-4-基-6-(硫酸基)-1,6-二氮杂双环[3.2.1]辛烷-2-甲酰胺的中间体的制备方法

Similar Documents

Publication Publication Date Title
KR100619639B1 (ko) 옥사졸리디논의 제조 방법
JPWO2020059891A5 (https=)
JP2015532645A5 (https=)
JP2018522012A5 (https=)
JP2008523069A5 (https=)
JPWO2019220276A5 (ja) 電子デバイス及び有機化合物
JP2023101503A5 (https=)
JP2007514047A5 (https=)
JP2004167667A5 (https=)
JP2018522925A5 (https=)
JPWO2021220648A5 (https=)
JP2017521430A5 (https=)
JP2014043437A5 (ja) 有機化合物
JP2016528262A5 (https=)
JP2017538836A5 (https=)
CN109053460B (zh) 一种催化苄醇类化合物胺化的方法
JP2023511152A5 (https=)
JP2021146505A5 (https=)
CN105622471A (zh) 一种蛋氨酸衍生物缓蚀剂的制备方法
JP2013538898A5 (https=)
CN111655703A (zh) 肝递送阿糖胞苷前体药物核苷环磷酸酯化合物及应用
CN110418797B (zh) 一种制备酮内酯化合物的方法
JP2018083792A5 (https=)
JP2015001400A5 (https=)
JP6809485B2 (ja) 酸ハライド溶液の製造方法、及びモノエステル化合物の製造方法